ThinkGenetic, Inc. (thinkgenetic.com) today announces the onboarding of entrepreneurial leader, Cian Robinson, MS, EdD-ABD as Chief Revenue Officer. Mr. Robinson is responsible for collaborating with potential ThinkGenetic clients to uncover opportunities for growth and partnership within ThinkGenetic.
In this second part, RV Radio continues the conversation with four members of the ThinkGenetic Leadership Team to focus the conversation on the day-to-day business and finding investment funding.
The ThinkGenetic leadership team was recently interviewed for the RV Radio podcast with Cian Robinson, discussing the origin of ThinkGenetic while giving insight into what it’s like to be diagnosed with a genetic condition later in life when doctors are stumped and existing tools to diagnose are limited.
ThinkGenetic combines modern machine learning with practical information in genetics to solve a major concern in healthcare – the identification of patients living with undiagnosed rare genetic conditions Boston, MA, […]
Development and implementation of an automated severity scoring system to identify patients at possible increased risk for specific genetic conditions NSGC 2021 Poster UM353
ThinkGenetic, Inc. announced today that it has been chosen out of a record-breaking 400-plus applicants as one of the top technology companies in the Southeast to be showcased at Venture Atlanta 2021.
Horizon Therapeutics plc (Nasdaq: HZNP), in collaboration with MIT Solve, a marketplace for social impact innovation, is proud to announce two winning solutions of this year’s Horizon Prize, ThinkGenetic Inc. and Congenica.
ThinkGenetic, Inc. announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund.
ThinkGenetic, Inc. is set to launch three disease-specific versions of the diagnostic aid, SymptomMatcher™ for upcoming pilot awareness initiatives by global biopharmaceutical leader, Takeda Pharmaceutical Company Limited.